Boehringer Ingelheim and Harvard scientists establish a research alliance to find novel treatments…
Business Wire IndiaBoehringer Ingelheim announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases such as idiopathic…
Read More...
Read More...